Consumer Health Cancer / Immunology
Thermo Fisher Scientific Introduces Tumor Culture Medium for Faster Cancer Treatment Development
Thermo Fisher Scientific, a global leading company in science services, today announced the launch of the Gibco™ OncoPro™ tumor media kit. *, t...
June 29, 2023 | News
Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET™ technology
By using this cutting-edge imaging technology in preclinical studies, Oncodesign Services’ team hopes to gain insights of the predictive effectivenes...
June 29, 2023 | News
INOVIQ's SubB2M/CA15-3 Breast Cancer Test Shows Excellent Clinical Data
INOVIQ's SubB2M/CA15-3 breast cancer test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%) The...
June 28, 2023 | News
CStone Receives China NMPA Approval for GAVRETO® in First-Line Treatment of RET Fusion-Positive Lung Cancer.
The approval for the first-line treatment of RET fusion-positive non-small cell lung cancer marks the third indication of GAVRETO in Mainland Chi...
June 27, 2023 | News
Prenetics and Prof. Dennis Lo Launch US$200m Joint Venture "Insighta" for Multi-Cancer Early Detection
- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo. - Insighta is powered by technology developed by the Centre for Novostics w...
June 26, 2023 | News
Lubrizol Licenses Award-Winning Apisolex™ Excipient to Welton Pharmaceuticals to Develop a Novel Cancer Therapeutic
The Lubrizol Corporation announces the licensing of its novel excipient polymer technology, Apisolex™ excipient, to Welton Pharma (Welton). The licen...
June 23, 2023 | News
Telix to Present ZIRCON Phase III Kidney Cancer Imaging Data at SNMMI
Further data from Telix's completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (Clinic...
June 23, 2023 | News
SeekIn paves the way for cancer early detection in low- and middle-income countries
The overall accuracy of TOO prediction in the true positives is 66.8%, which may be supportive in the clinical diagnostic workup. OncoSeek® ...
June 19, 2023 | News
FDA Approves Phase I/II Trial for Leads Biolabs' Anti-MUC16/CD3 Bispecific Antibody in Advanced Solid Tumors.
The study is a multicenter, open-label, dose-escalation and expansion phase Ⅰ/Ⅱ clinical study. The phase Ⅰ part aims to evaluate the safety, to...
June 19, 2023 | News
FDA Approves Utidelone Injectable (UTD1) Trial for Non-Small Cell Lung Cancer
Designated as BG01-2202, this trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable (UTD1) v...
June 16, 2023 | News
NCCN Unveils Thyroid Cancer Care Roadmap for Low- and Middle-Income Countries on Global Stage
The National Comprehensive Cancer Network® (NCCN®) is introducing a new global resource to improve thyroid cancer care in low- and middle-inco...
June 15, 2023 | News
Biostar Pharma Enrolls First Patient for Phase 1 Study of UTD2, World's First Oral Epothilone Anti-Cancer Drug
This study will be conducted at multiple clinical research centers including Sarah Cannon Research Institute (Florida Cancer Specialists & Research Ins...
June 13, 2023 | News
Lunit's Groundbreaking AI Research Transforms Medical Pathology with Computer Vision, Presented at CVPR 2023
Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer diagnostic solutions, announced its participation in the Conference on Computer...
June 13, 2023 | News
HKSH Medical Group and UCLA Health signed a Development Agreement
HKSH Medical Group (HKSH) and UCLA Health have signed a Development Agreement to strengthen their partnership in knowledge transfer in cancer management. T...
June 13, 2023 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
